Feed aggregator

ATLANTA--(BUSINESS WIRE)--Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) (the “Company,” “we,” and “our”), a leading real estate finance company focused on acquiring and investing in first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market, announced today that the Company will release its second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. A conference call will be held that day at 8:30 a.m. Eastern Time. Webcast: A webcast of the

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) today reported a net loss attributable to common shareholders of $2.9 million, or $(0.04) per common share for the second quarter of 2025, on net investment income of $70.2 million. PMT previously announced a cash dividend for the second quarter of 2025 of $0.40 per common share of beneficial interest, which was declared on June 25, 2025, and will be paid on July 25, 2025, to common shareholders of record

NEW YORK--(BUSINESS WIRE)--Granite Point Mortgage Trust Inc. Announces Dates for Second Quarter 2025 Earnings Release and Conference Call

CENTER VALLEY, Pa.--(BUSINESS WIRE)---- $FOUR--Shift4 (NYSE: FOUR), the leader in integrated payments and commerce technology, today announced the date for the release of its second quarter 2025 financial results. Q2 2025 Earnings Conference Call Shift4 will release its second quarter 2025 financial results pre-market open on Tuesday, August 5, 2025. Management will also host a conference call at 8:30am ET to review these results. Conference Call Details Toll-free dial-in: +1-877-407-0613 Toll dial-in: +

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--1st Colonial Bancorp, Inc. Announces Second Quarter 2025 Earnings

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to ten classes of mortgage-backed notes from BRAVO Residential Funding Trust 2025-NQM7 (BRAVO 2025-NQM7). The $503.7 million RMBS transaction is collateralized by a pool of 985 residential mortgages, with fixed-rate mortgages (FRMs) and hybrid adjustable-rate mortgages (ARMs) making up 98.3% and 1.7% of the pool, respectively. Most loans are either classified as non-qualified mortgages (Non-QM) (43.9%) or exempt (47.2%) from the Abilit

WASHINGTON, Pa.--(BUSINESS WIRE)--CB Financial Services, Inc. (“CB” or the “Company”) (NASDAQGM: CBFV), the holding company of Community Bank (the “Bank”), today announced its second quarter and year-to-date 2025 financial results.   Three Months Ended   Six Months Ended   6/30/25 3/31/25 12/31/24 9/30/24 6/30/24   6/30/25 6/30/24 (Dollars in thousands, except per share data) (Unaudited)                                 Net Income (GAAP) $ 3,949 $ 1,909 $ 2,529 $ 3,219 $ 2,650   $ 5,858 $ 6,847

CHICAGO--(BUSINESS WIRE)--Kemper Corporation (NYSE: KMPR) today announced that after the markets close on Tuesday, August 5, Kemper intends to issue its second quarter 2025 earnings release, financial supplement, and Form 10-Q. Following their publication, these documents will be available in the investor section of kemper.com. Conference Call Details Kemper will host its conference call to discuss second quarter 2025 results on Tuesday, August 5, at 5:00 pm Eastern (4:00 pm Central). The confe

NEW YORK--(BUSINESS WIRE)-- #mcb--Metropolitan Commercial Bank (the “Bank,” “MCB”), a full-service commercial bank headquartered in New York City, is proud to announce its official certification as a Great Place To Work® by a global authority on workplace culture, employee experience, and leadership behaviors. The certification reflects MCB’s unwavering commitment to cultivating a supportive, comprehensive, and growth-driven environment for its bankers and employees. It marks a significant milestone a

MCLEAN, Va.--(BUSINESS WIRE)--Capital One Financial Corporation (NYSE: COF) today announced net loss for the second quarter of 2025 of $4.3 billion, or $(8.58) per diluted common share, compared with net income of $1.4 billion, or $3.45 per diluted common share in the first quarter of 2025, and with net income of $597 million, or $1.38 per diluted common share in the second quarter of 2024. Adjusted net income(1) for the second quarter of 2025 was $5.48 per diluted common share. "We completed o

NEW YORK--(BUSINESS WIRE)--Zeta Global Announces Fifth-Annual Zeta Live 2025 Conference, Headlined by Seven-Time Super Bowl Champion Tom Brady

NEW YORK--(BUSINESS WIRE)--The Board of Directors of American Express Company (NYSE: AXP) declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $9,072.22 per share (which is equivalent to $9.07222 per related Depositary Share). The dividend is payable on September 15, 2025, to shareholders of record on September 1, 2025. ABOUT AMERICAN EXPRESS American Express (NYSE: AXP) is a global payments and premium lifestyle brand powered by te

PLANO, Texas--(BUSINESS WIRE)--Finance of America Companies Inc. (“Finance of America” or the “Company”) (NYSE: FOA), a leading provider of home equity-based financing solutions for a modern retirement, today announced that it will release results for the second quarter ended June 30, 2025 after market closing on Tuesday, August 5, 2025. Webcast and Earnings Conference Call Management will host a webcast and conference call on the same day at 5:00 pm Eastern Time to discuss the Company’s result

PASADENA, Calif.--(BUSINESS WIRE)--East West Bancorp, Inc. (“East West” or the “Company”) (Nasdaq: EWBC), parent company of East West Bank, reported its financial results for the second quarter of 2025. Second quarter 2025 net income was $310 million or $2.24 per diluted share. Total loans and deposits both reached new records as of June 30, 2025, at $55.0 billion and $65.0 billion respectively. Return on average common equity was 15.4% and the total stockholders’ equity to assets ratio was 10.

LEBANON, Ohio--(BUSINESS WIRE)--LCNB Corp. ("LCNB") (NASDAQ: LCNB) today announced financial results for the three and six months ended June 30, 2025. Commenting on the financial results, LCNB President and Chief Executive Officer, Eric Meilstrup said, “LCNB delivered a strong second quarter, reflecting continued momentum across our core operations and the success of our multi-year growth strategies. Second-quarter net interest margin expanded year-over-year by 61 basis points as a result of pr

FAIRFAX, Va.--(BUSINESS WIRE)--FVCBankcorp, Inc. Announces Sixth Consecutive Quarter of Improved Earnings; Return on Average Assets 1.02% for the Second Quarter of 2025

CHICAGO--(BUSINESS WIRE)--The Chicago chapter of NIRI has elected 12 officers and directors to its board for the 2025-2026 term.

WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (“FTA”) announced today that the Board of Trustees (the “Board”) of First Trust Exchange-Traded Fund VIII (the “Trust”), on behalf of FT Confluence BDC & Specialty Finance ETF (the “Fund”), an actively-managed exchange-traded fund (NYSE Arca: FBDC), approved a 1-for-5 reverse share split. The reverse share split will result in every five outstanding shares of the Fund being converted into one share of the Fund, with any resulting fra

OLD TOWN ALEXANDRIA, Va.--(BUSINESS WIRE)--Pandion Optimization Alliance, a leader in group purchasing optimization, recently hosted its third annual GOAT (Greatest of All Time) Awards ceremony at the Hummingbird Kitchen and Bar in Old Town Alexandria, VA. The event, held during Premier Inc's Breakthroughs25 conference, celebrated the outstanding achievements and partnerships that have driven success in the GPO space over the past year. Travis Heider, President and CEO of Pandion, spoke at the

NEW YORK--(BUSINESS WIRE)---- $REPL #Attorney--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal securities laws. If you invested in Replimune, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/replimune-group-class-action-lawsuit. Why is Replimune being Investigated? Replimune is a clinical-stage biotechnology company focused on developing